Clinical Trials Logo

Hearing Loss, Sensorineural clinical trials

View clinical trials related to Hearing Loss, Sensorineural.

Filter by:

NCT ID: NCT05488535 Completed - Hearing Loss Clinical Trials

Non-significant Risk Study of a Cochlear Implant Headpiece

Start date: February 28, 2019
Phase:
Study type: Interventional

This study aims to evaluate a cochlear implant headpiece.

NCT ID: NCT05441891 Completed - Clinical trials for Asymmetric Sensorineural Hearing Loss

Effect of Modulated Auditory Stimulation on Interaural Auditory Perception

Start date: June 17, 2022
Phase: N/A
Study type: Interventional

This study analyzes the effect of an equalizer-modulated auditory intervention on the asymmetry of interaural auditory perception in groups with different emotional states such as well-being, anxiety, depression and mixed anxiety-depression.

NCT ID: NCT05423548 Completed - Clinical trials for Congenital Sensorineural Hearing Loss

Analysis of Risk Factors of Neurodevelopmental Disorder in Deaf Infants Under Ten Months of Age.

EnTNDre
Start date: August 3, 2022
Phase:
Study type: Observational

Among risk factors of neurodevelopmental disorder is congenital hearing loss. However, congenital deafness is neither necessary nor sufficient for the occurrence of warning signs of neurodevelopmental disorder. The investigative team hypothesizes that the co-occurrence of these two clinical entities results from a common origin, within a syndromic diagnosis including other medical issues. These situations would therefore be very different from those of babies suffering from isolated sensorineural deafness. This study aims to identify which factors are statistically correlated with the association of congenital deafness and early symptoms of neurodevelopmental disorder, thanks to a partnership between a regional center for psychiatry of deaf children (Therapeutic Childhood and Deafness Unit of St Maurice Hospitals, UTES) and a pediatric audiophonology department (ENT department of the Necker-Enfants Malades hospital). This work is based on a cohort of 26 children under ten months of age diagnosed with severe to profound congenital sensorineural hearing loss. As part of their pre-implantation cochlear assessment, a consultation was filmed to precisely analyze the interactional and sensorimotor skills of these children (clinical observations, administration of a specific evaluation grid called Olliac Grid), after reviewing the films. The investigative team will then be able to grade the neurodevelopmental risk. In order to clarify what factors are linked with a neurodevelopmental risk, medical data concerning the child's family context, birth, and audiological profile will also be collected, and put in perspective with the assessed neurodevelopmental risk gradation.

NCT ID: NCT05299892 Completed - Clinical trials for Hearing Loss, Sensorineural

Optimizing Soft Speech Recognition in Children With Hearing Loss

SoftSpeech
Start date: March 21, 2022
Phase: N/A
Study type: Interventional

Overhearing is important for vocabulary learning and speech and language development in young children. However, contemporary hearing aids are generally unable to provide adequate access to low-level auditory inputs from multiple talkers at a distance to capitalize on overhearing. A recent investigation by Jace Wolfe and colleagues showed that, even when aided, children with hearing loss had significantly poorer speech recognition at 40, 50 and 60 dBA compared to children with normal hearing. Furthermore, they showed that increasing hearing aid gain for very low-level inputs produced a statistically significant improvement in syllable-final plural recognition and a non-significant trend toward better monosyllabic word recognition at very low presentation levels. Additional research is needed to document low-level speech recognition ability of children with hearing loss as well as the potential benefit or detriment of increasing hearing aid gain for low-level inputs. A novel hearing aid technology known as Soft Speech Enhancer has been shown improve low-level speech perception in adults with hearing loss; however, the effect of Speech Enhancer on speech recognition in children is not yet known and will be evaluated.

NCT ID: NCT05292534 Completed - Tinnitus Clinical Trials

Evaluation of the Clinical Benefit of the Hearing Aids Tinnitus Feature.

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

Participants with hearing loss and Tinnitus will wear hearing aids with amplification-only or with an added sound, and have their tinnitus level evaluated before and after intervention.

NCT ID: NCT05286385 Completed - Clinical trials for Hearing Impairment, Sensorineural

CP1150 Sound Processor Speech Perception Compared With the Next Generation of Signal Processing Technology

Start date: May 30, 2022
Phase: N/A
Study type: Interventional

This clinical study aims to investigate speech performance in quiet with an OTE Sound Processor with modified firmware compared with the commercially available CP1150. The study also investigates CP1110 and CP1150 with Forward Focus.

NCT ID: NCT05265260 Completed - Clinical trials for Sensorineural Hearing Loss, Bilateral

Factors Affecting Early Progress of Cochlear Implant Outcomes in Adults

PROGRESS
Start date: April 21, 2022
Phase:
Study type: Observational

The aim of this study is to understand how audiometric, cognitive and electrophysiological results relate to sentence recognition score in adults using currently a Nucleus cochlear implant.

NCT ID: NCT05244603 Completed - Clinical trials for Hearing Loss, Sensorineural

Application of Ideal Binary Masking to Disordered Speech

Start date: December 1, 2021
Phase: Early Phase 1
Study type: Interventional

Dysarthria and hearing loss are communication disorders that can substantially reduce intelligibility of speech and the addition of background noise adds a further challenge. This proposal utilizes an established signal processing technique, currently exploited for improved understanding of speech in noise for listeners with hearing loss, to investigate its potential application to overcome speech-in-noise difficulties for listeners understanding dysarthric speech. Successful completion of this project will demonstrate proof-of-concept for the application of this signal processing technique to dysarthric speech in noise, and inform the development of an R01 proposal to perform a large-scale evaluation of the technology, and clinically meaningful implications, in a broad range of disordered speech types and severities.

NCT ID: NCT05237180 Completed - Clinical trials for Hearing Loss, Cochlear

Evaluation of the Effect of a Spatial Localization Training Program on Auditory Comprehension

CAudiBruit
Start date: February 15, 2022
Phase: N/A
Study type: Interventional

Hearing comprehension under complex listening conditions is considered to be the central complaint of everyday life for patients with cochlear implants. Localization is one of the cues for listening comprehension. However, only few studies have investigated the effect of spatial localization training on listening comprehension performance in noise. None of these studies correspond to the desire to purpose training by speech therapists while using affordable equipment. The main objective of this study is to evaluate the effect of a spatial localization training protocol in cochlear bi-implanted subjects with post-lingual deafness on their ability to understand in noise. 2 groups of 10 subjects each will be recruited: a patient group and a control group. The patient group will undergo 8 sessions of spatial localization rehabilitation lasting an average of 45 minutes each. After this programme, the pre-test and post- test results obtained will be compared.

NCT ID: NCT05198713 Completed - Clinical trials for Hearing Loss, Sensorineural

Evaluation of Hearing Aid Benefit

Start date: January 18, 2022
Phase: N/A
Study type: Interventional

The present study will investigate the benefit of hearing aids for speech intelligibility (in both quiet and noisy environments) compared to the unaided condition. Participants will include adults with moderate to moderately severe hearing impairment. The participants will complete laboratory-based speech intelligibility assessments with binaural hearing aids and without hearing aids.